Trade secrets managers should take note: a UK law criminalising theft is now in play
The National Security Act 2023 gives an extra layer of protection to trade secrets against foreign espionage and moves prosecution to government control
The National Security Act 2023 gives an extra layer of protection to trade secrets against foreign espionage and moves prosecution to government control
IAM speaks exclusively to Jordi Ilario about the Catalan licensing business’s Vivint deal and ongoing projects
Everything you need to know about how the Chapter 11 process impacts the companies’ high-profile spat
IAM talks exclusively to two of the top European scientists speaking out against the “harmful” new licensing framework
29 January 2024
The data storage firm’s loss was the fourth-highest award in the last 12 months, with Google’s $338.8 million defeat topping the heap
08 January 2024
The speedy agreement prevents litigation between the two parties, but other Cas9 disputes may be on the cards
14 December 2023
Friday’s green light from the FDA is watershed for IP strategy in the field
11 December 2023
TwinStrand co-founder’s grandfather famously didn’t patent the polio vaccine, but Dr Jesse Salk believes that protecting inventions is key to getting products to reach the market
05 December 2023
Green light for first ever Cas9 therapy ushers in next phase of licensing and litigation efforts.
17 November 2023
Chief Legal Officer Yoori Kim argues that current patent uncertainty should fuel rather than thwart licensing deals
01 November 2023
The surge is due to 9,702 US patent assets involved in the BlackBerry sale to Key Patent Innovations, which runs Malikie Innovations, according to the AST Patent Deals Report for Q2 2023
15 September 2023
Pathbreaking joint venture between academia and Big Pharma addresses university IP monetisation challenges
12 September 2023
Narrow safe harbor immunity and platform technology patents are creating both pitfalls and opportunities
08 September 2023
Unlock unlimited access to all IAM content